February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking the sixth successful implantation of the Stentys bifurcated stent platform.
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...
February 4, 2008 - Heart conditions cost $76 billion to treat in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
February 1, 2008 - NightHawk Radiology will be a radiology provider for the High-Risk Plaque Initiative (HRP Initiative), a joint research effort to advance the understanding and management of high-risk plaque, which is believed to be the primary underlying cause of heart attacks and strokes.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
January 30, 2008 - Cardiac Science Corp. won two contracts to supply Powerheart automated external defibrillators (AEDs) ...
January 30, 2008 - Aporo Biomedical signed an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP), enabling Aporo to offer devices with biodegradable closure features for treating structural heart diseases such as PFO and ASD.
January 30, 2008 - NightHawk Radiology is the exclusive radiology provider for the High-Risk Plaque Initiative, called ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
January 30, 2008 - Iroko Pharmaceuticals (Iroko) acquired all non-U.S. commercial rights to Aggrastat (tirofiban HCl) from Merck & Co. Inc., used for patients undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications, in a move Iroko hopes will strengthen its presence in the cardiovascular market.
January 30, 2008 - TopSpin Medical Inc. installed the Cathamaran Intravascular MRI System at ZOL Hospital in Belgium, marking the first installation of the system and its entrance in a study on vulnerable plaque.
January 30, 2008 - Cardica Inc.’s C-Port Distal Anastomosis Systems will be used in two courses to train cardiothoracic ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
January 30, 2008 - TopSpin Medical Inc. announced the first commercial installation of the Cathamaran Intravascular MRI System at ZOL Hospital, Genk, Belgium, with the first procedures performed on Jan. 16.
Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system ...
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
January 31, 2008
